AMA advocacy efforts: Population care and health disparities

In addition to the work AMA is doing on the recovery plan, we are also advocating at the federal and state levels on key issues related to population coverage and health inequalities.

Subscribe to the AMA Advocacy Update

Keep up to date with the issues affecting physicians, patients and the healthcare environment with the AMA Advocacy Update Newsletter.

  • Joint letters with the American College of Obstetricians and Gynecologists to the White House (PDF) and the Food and Drug Administration (PDF) in support of unrestricted access to mifepristone.
  • Released a statement declaring the Supreme Court decision in Dobbs v. Jackson Women’s Health Organization an outrageous endorsement of government intervention in medicine.
  • In response to the Supreme Court decision in Dobbs v. Jackson Women’s Health Organization, the AMA supported new HHS privacy guidelines that clarify that physicians are not required to share private medical information with third parties and provide tips for patients on using private cell phones and tablets .
  • AMA President Jack Resneck Jr., MD, testified before the House Committee on Energy and Commerce Subcommittee on Oversight and Investigations during his hearing “Roe Reversal: The Impacts of Taking Away the Constitutional Right to an Abortion.”
  • Joined the American College of Obstetricians and Gynecologists and more than 75 other medical societies to speak out unanimously against legal interference in the relationship between patients, physicians and other health care professionals.
  • Applauded President Biden’s executive order pledging to explore ways to protect access to reproductive health services.
  • The AMA supports government guidance on lifting state bans on abortion by EMTALA and has submitted amicus briefs Texas vs. Becerra and United States vs. Idaho on the subject.
  • The AMA has filed a series of amicus briefs challenging state bans on abortion.
  • Over two-thirds of states have taken steps to extend Medicaid coverage for women after childbirth from 60 days to 12 months after childbirth.
    • 13 states have implemented postpartum Medicaid extensions.
    • 19 states have approved or are in the process of expanding coverage for women after childbirth.
  • AMA supported passage of the Protecting Moms Who Served Act of 2021.
  • The FY2022 omnibus package included nearly $1 billion for maternal health priorities.
  • The AMA has sponsored several bills, including:
    • The TRIUMPH for New Moms Act of 2021, which would establish a Maternal Mental Health Task Force to identify, evaluate and make recommendations to coordinate and improve federal responses to maternal mental health problems, and a national strategic plan to address them of maternal mental health to create health disorders.
    • The MOMMA’s Act, which consists of five main components, including providing technical assistance to States in reporting maternal deaths; issuing best practices to State Maternal Mortality Review Boards (MMRCs); Expansion of Medicaid and CHIP coverage for postpartum care from 60 days to one year; Support for the Alliance for Innovation on Maternal (AIM); and establishment of regional centers of excellence.
    • The Data Mapping to Save Moms’ Lives Act, which would direct the Federal Communications Commission to consult with the US Centers for Disease Control and Prevention (CDC) to find ways to map maternal health outcomes data for Integrate health mapping tools into broadband at least one year postpartum to reduce maternal mortality and morbidity in the US
  • Issued a statement against the draft Opinion of the Supreme Court for the Dobbs vs. Jackson Women’s Health Organization Fall and submitted an amicus brief (PDF) to more than two dozen leading medical organizations.
  • Developed a model state law to protect pregnant, parenting, and postpartum individuals and families with a substance use disorder to receive evidence-based treatment without facing punitive action.
  • Successfully urged the administration to fix the “family mistake” and provide affordable health insurance.
  • Working with healthcare stakeholders, the government called on the government to maintain the public health emergency, which extends coverage of care and extends key regulatory flexibilities until there is an extended period of greater stability.
  • It has successfully pushed for the adoption of stricter network adequacy rules for qualified health plans and Medicare Advantage plans.
  • Driven (PDF) to permanently expand health insurance premium tax credits to ensure millions of low- and middle-income families continue to have access to affordable coverage in 2023 and beyond.
  • Published in 2022 and Beyond: AMA’s Plan to Cover the Uninsured (PDF), which includes specific policy proposals that not only target the populations who remain uninsured, but also steps that can be taken to improve premium affordability and cost-sharing to improve.
  • The AMA is currently lobbying for a wide range of immigration and border security policy changes, including those that would ease visa restrictions on foreign-born physicians wishing to train or practice in the United States
  • Submitted a statement to the US House of Representatives Committee on the Judiciary Subcommittee on Immigration and Citizenship for the Minutes (PDF) on Physician Immigration and Labor Shortages.
  • CDC announced the full repeal of Title 42, which allowed the U.S. Department of Homeland Security (DHS) to expel migrants at the border based on their country of origin, travel route, or likelihood of contracting a communicable disease like COVID. 19
  • Advocates to various stakeholders that more needs to be done to address why treatment experiences and clinical outcomes vary by race/ethnicity and encourage additional efforts to improve outcomes and satisfaction for historically inferior patients treated by physicians without racial concordance are treated.

Learn about our efforts covered in the AMA Recovery Plan for America’s Physicians, public health and pandemic response, and removing barriers to treatment.


Leave a Reply

Your email address will not be published. Required fields are marked *